RDS
Strasbourg
About RDS
RDS develops solutions for continuous and remote patient monitoring to improve patient pathways in healthcare. The company’s main product, MultiSense®, is a wearable, multi-parametric biosensor that monitors key physiological parameters both in hospitals and at home. This device enables healthcare professionals to detect changes in patient conditions, support early hospital discharge, and reduce hospital stays. By integrating digital health technologies and predictive medicine, RDS contributes to better postoperative outcomes and enhanced recovery processes. Its innovations are designed to optimize patient management, improve quality of life, and support more sustainable healthcare systems.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $25.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: rdsdiag.com
- Phone: +33 390-413600
Industries & Categories
Health Care, Medical, Medical Device, Wearables
Social Profiles
Canonical: https://fsome.com/organization/rds-19480 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.